Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-13-163161
Filing Date
2013-04-22
Accepted
2013-04-19 17:56:52
Documents
5
Period of Report
2013-04-19

Document Format Files

Seq Description Document Type Size
1 6-K d525780d6k.htm 6-K 10393
2 EX-99.1 d525780dex991.htm EX-99.1 95035
3 GRAPHIC g525780img1.jpg GRAPHIC 31246
4 GRAPHIC g525780img2.jpg GRAPHIC 5431
5 GRAPHIC g525780img3.jpg GRAPHIC 12176
  Complete submission text file 0001193125-13-163161.txt   174130
Mailing Address LEVEL 7, 151 MACQUARIE STREET SYDNEY, NEW SOUTH WALES C3 2000
Business Address LEVEL 7, 151 MACQUARIE STREET SYDNEY, NEW SOUTH WALES C3 2000 612 9276 1224
Prima BioMed Ltd (Filer) CIK: 0001506184 (see all company filings)

EIN.: 000000000
Type: 6-K | Act: 34 | File No.: 001-35428 | Film No.: 13772428
SIC: 2834 Pharmaceutical Preparations